First Time Loading...
T

TMS Co Ltd
TSE:4891

Watchlist Manager
TMS Co Ltd
TSE:4891
Watchlist
Price: 242 JPY -0.41% Market Closed
Updated: May 15, 2024

Profitability Summary

TMS Co Ltd's profitability score is 28/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

28/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

28/100
Profitability
Score
28/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
TMS Co Ltd

Revenue
0 JPY
Operating Expenses
-674m JPY
Operating Income
-674m JPY
Other Expenses
2m JPY
Net Income
-672.1m JPY

Margins Comparison
TMS Co Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
JP
TMS Co Ltd
TSE:4891
8.9B JPY N/A N/A
US
Abbvie Inc
NYSE:ABBV
289.1B USD
30%
9%
US
Amgen Inc
NASDAQ:AMGN
171.1B USD
24%
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD
39%
37%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.8B USD
30%
29%
AU
CSL Ltd
ASX:CSL
136.7B AUD
26%
17%
US
Gilead Sciences Inc
NASDAQ:GILD
83.7B USD
32%
2%
US
Moderna Inc
NASDAQ:MRNA
49.3B USD
-100%
-116%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-33%
-33%
US
Biogen Inc
NASDAQ:BIIB
34.2B USD
22%
12%
KR
Celltrion Inc
KRX:068270
39.6T KRW
30%
25%
Country JP
Market Cap 8.9B JPY
Operating Margin N/A
Net Margin N/A
Country US
Market Cap 289.1B USD
Operating Margin
30%
Net Margin
9%
Country US
Market Cap 171.1B USD
Operating Margin
24%
Net Margin
13%
Country US
Market Cap 112.7B USD
Operating Margin
39%
Net Margin
37%
Country US
Market Cap 107.8B USD
Operating Margin
30%
Net Margin
29%
Country AU
Market Cap 136.7B AUD
Operating Margin
26%
Net Margin
17%
Country US
Market Cap 83.7B USD
Operating Margin
32%
Net Margin
2%
Country US
Market Cap 49.3B USD
Operating Margin
-100%
Net Margin
-116%
Country US
Market Cap 43.1B USD
Operating Margin
-33%
Net Margin
-33%
Country US
Market Cap 34.2B USD
Operating Margin
22%
Net Margin
12%
Country KR
Market Cap 39.6T KRW
Operating Margin
30%
Net Margin
25%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
TMS Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
TMS Co Ltd
TSE:4891
8.9B JPY
-19%
-19%
-19%
-392%
US
Abbvie Inc
NYSE:ABBV
289.1B USD
35%
4%
16%
13%
US
Amgen Inc
NASDAQ:AMGN
171.1B USD
73%
4%
10%
9%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD
23%
18%
22%
44%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.8B USD
15%
12%
14%
17%
AU
CSL Ltd
ASX:CSL
136.7B AUD
15%
7%
11%
9%
US
Gilead Sciences Inc
NASDAQ:GILD
83.7B USD
3%
1%
18%
7%
US
Moderna Inc
NASDAQ:MRNA
49.3B USD
-38%
-29%
-29%
-56%
US
Seagen Inc
NASDAQ:SGEN
43.1B USD
-28%
-21%
-27%
-39%
US
Biogen Inc
NASDAQ:BIIB
34.2B USD
8%
5%
9%
8%
KR
Celltrion Inc
KRX:068270
39.6T KRW
5%
4%
6%
4%
Country JP
Market Cap 8.9B JPY
ROE
-19%
ROA
-19%
ROCE
-19%
ROIC
-392%
Country US
Market Cap 289.1B USD
ROE
35%
ROA
4%
ROCE
16%
ROIC
13%
Country US
Market Cap 171.1B USD
ROE
73%
ROA
4%
ROCE
10%
ROIC
9%
Country US
Market Cap 112.7B USD
ROE
23%
ROA
18%
ROCE
22%
ROIC
44%
Country US
Market Cap 107.8B USD
ROE
15%
ROA
12%
ROCE
14%
ROIC
17%
Country AU
Market Cap 136.7B AUD
ROE
15%
ROA
7%
ROCE
11%
ROIC
9%
Country US
Market Cap 83.7B USD
ROE
3%
ROA
1%
ROCE
18%
ROIC
7%
Country US
Market Cap 49.3B USD
ROE
-38%
ROA
-29%
ROCE
-29%
ROIC
-56%
Country US
Market Cap 43.1B USD
ROE
-28%
ROA
-21%
ROCE
-27%
ROIC
-39%
Country US
Market Cap 34.2B USD
ROE
8%
ROA
5%
ROCE
9%
ROIC
8%
Country KR
Market Cap 39.6T KRW
ROE
5%
ROA
4%
ROCE
6%
ROIC
4%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More